MedPath

Little Green Pharma Ltd

Ownership
-
Employees
-
Market Cap
-
Website
Introduction

Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

TGA:14

Drug Approvals

CBD 200 LGP PURE (470485)

Product Name
CBD 200 LGP PURE
Approval Date
Nov 26, 2024
TGA

1:100 LGP CLASSIC (385000)

Product Name
1:100 LGP CLASSIC
Approval Date
Mar 2, 2022
TGA

DEMECAN 22:01 FLORESTURA (357695)

Product Name
DEMECAN 22:01 FLORESTURA
Approval Date
Mar 25, 2021
TGA

DEMECAN 24:01 FLORESTURA (357670)

Product Name
DEMECAN 24:01 FLORESTURA
Approval Date
Mar 25, 2021
TGA

DEMECAN 16:01 FLORESTURA (352227)

Product Name
DEMECAN 16:01 FLORESTURA
Approval Date
Dec 23, 2020
TGA

DEMECAN 20:01 FLORESTURA (352225)

Product Name
DEMECAN 20:01 FLORESTURA
Approval Date
Dec 23, 2020
TGA

DEMECAN 18:01 FLORESTURA (352226)

Product Name
DEMECAN 18:01 FLORESTURA
Approval Date
Dec 23, 2020
TGA

CBD 50 LGP CLASSIC (334361)

Product Name
CBD 50 LGP CLASSIC
Approval Date
Apr 16, 2020
TGA

T1:C20 LGP CLASSIC (330203)

Product Name
T1:C20 LGP CLASSIC
Approval Date
Feb 20, 2020
TGA

1:20 LGP CLASSIC (329380)

Product Name
1:20 LGP CLASSIC
Approval Date
Feb 3, 2020
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.